Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2...

por Liu, Binliang, Xie, Ning, Tian, Can, Feng, Ronghua, Hu, Zhe-Yu, Li, Jing, Liu, Liping, Xiao, Huawu, Yang, Xiaohong, Zeng, Mengsi, Wu, Hui, Lu, Jun, Gao, Jianxiang, Hu, Xuming, Cao, Min, Shui, Zhengrong, Tang, Yu, Wu, Tao, Ouyang, Quchang
Publicado 2023